1/31
04:35 pm
abbv
AbbVie (NYSE:ABBV) Posts Better-Than-Expected Sales In Q4, Stock Soars [Yahoo! Finance]
Low
Report
AbbVie (NYSE:ABBV) Posts Better-Than-Expected Sales In Q4, Stock Soars [Yahoo! Finance]
1/31
02:52 pm
abbv
AbbVie (ABBV) Q4 2024 Earnings Call Transcript [Yahoo! Finance]
Low
Report
AbbVie (ABBV) Q4 2024 Earnings Call Transcript [Yahoo! Finance]
1/31
11:32 am
abbv
Compared to Estimates, AbbVie (ABBV) Q4 Earnings: A Look at Key Metrics [Yahoo! Finance]
Low
Report
Compared to Estimates, AbbVie (ABBV) Q4 Earnings: A Look at Key Metrics [Yahoo! Finance]
1/31
11:08 am
abbv
AbbVie earnings: Analyst weighs in on drug pipeline, HHS hearing [Yahoo! Finance]
Low
Report
AbbVie earnings: Analyst weighs in on drug pipeline, HHS hearing [Yahoo! Finance]
1/31
11:00 am
abbv
AbbVie earnings: Analyst weighs in on drug pipeline, HHS hearing [Yahoo! Finance Canada]
Low
Report
AbbVie earnings: Analyst weighs in on drug pipeline, HHS hearing [Yahoo! Finance Canada]
1/31
09:53 am
abbv
AbbVie stock rises on solid annual profit guidance, Q4 beat [Yahoo! Finance]
Low
Report
AbbVie stock rises on solid annual profit guidance, Q4 beat [Yahoo! Finance]
1/31
07:45 am
abbv
AbbVie forecasts 2025 profit above estimates, driven by newer immunology drugs [Yahoo! Finance Canada]
Low
Report
AbbVie forecasts 2025 profit above estimates, driven by newer immunology drugs [Yahoo! Finance Canada]
1/31
07:36 am
abbv
AbbVie Reports Full-Year and Fourth-Quarter 2024 Financial Results
Medium
Report
AbbVie Reports Full-Year and Fourth-Quarter 2024 Financial Results
1/31
07:07 am
abbv
Body Augmentation Fillers Market Analysis Report 2024: Global Market to Surpass $7 Billion by 2035 [Yahoo! Finance]
Medium
Report
Body Augmentation Fillers Market Analysis Report 2024: Global Market to Surpass $7 Billion by 2035 [Yahoo! Finance]
1/30
02:04 pm
abbv
If You Invested $10,000 In AbbVie Stock 10 Years Ago, How Much Would You Have Now? [Yahoo! Finance]
Neutral
Report
If You Invested $10,000 In AbbVie Stock 10 Years Ago, How Much Would You Have Now? [Yahoo! Finance]
1/29
04:00 am
abbv
Allergan Aesthetics launches new AA Signature Program at IMCAS 2025 to redefine patient-centric, multimodal treatment plans
Low
Report
Allergan Aesthetics launches new AA Signature Program at IMCAS 2025 to redefine patient-centric, multimodal treatment plans
1/28
08:00 am
abbv
AbbVie Inc. (NYSE: ABBV) had its price target lowered by analysts at Citigroup Inc. from $215.00 to $205.00. They now have a "buy" rating on the stock.
Low
Report
AbbVie Inc. (NYSE: ABBV) had its price target lowered by analysts at Citigroup Inc. from $215.00 to $205.00. They now have a "buy" rating on the stock.
1/27
09:17 am
abbv
AbbVie A Top Socially Responsible Dividend Stock With 3.9% Yield [Forbes]
Low
Report
AbbVie A Top Socially Responsible Dividend Stock With 3.9% Yield [Forbes]
1/24
04:00 am
abbv
Allergan Aesthetics unveils new AA Signature Program and immersive booth at IMCAS World Congress 2025
Low
Report
Allergan Aesthetics unveils new AA Signature Program and immersive booth at IMCAS World Congress 2025
1/23
09:16 am
abbv
AbbVie Completes Acquisition of Nimble Therapeutics
Low
Report
AbbVie Completes Acquisition of Nimble Therapeutics
1/23
09:00 am
abbv
AbbVie and Neomorph Announce Collaboration to Develop Molecular Glue Degraders for Oncology and Immunology
Low
Report
AbbVie and Neomorph Announce Collaboration to Develop Molecular Glue Degraders for Oncology and Immunology
1/16
12:15 am
abbv
Alzheimer's Disease Therapeutics Market size to increase by USD 5.41 Billion between 2023 to 2028, Market Segmentation by Distribution Channel, Drug Class, Geography , Technavio [Yahoo! Finance]
Low
Report
Alzheimer's Disease Therapeutics Market size to increase by USD 5.41 Billion between 2023 to 2028, Market Segmentation by Distribution Channel, Drug Class, Geography , Technavio [Yahoo! Finance]
1/15
05:23 am
abbv
Umoja secures $100m to advance CAR-T cell therapy pipeline [Yahoo! Finance]
Low
Report
Umoja secures $100m to advance CAR-T cell therapy pipeline [Yahoo! Finance]
1/14
05:43 am
abbv
Neuromuscular Disease Therapeutics Market to Grow by USD 13.73 Billion from 2025-2029, Driven by Novel Approvals and AI-Driven Market Transformation - Technavio [Yahoo! Finance]
Low
Report
Neuromuscular Disease Therapeutics Market to Grow by USD 13.73 Billion from 2025-2029, Driven by Novel Approvals and AI-Driven Market Transformation - Technavio [Yahoo! Finance]
1/13
09:05 am
abbv
Simcere Zaiming and AbbVie Announce Partnership to Develop a Novel Trispecific Antibody Candidate in Multiple Myeloma
Low
Report
Simcere Zaiming and AbbVie Announce Partnership to Develop a Novel Trispecific Antibody Candidate in Multiple Myeloma
1/13
09:05 am
abbv
Simcere Zaiming and AbbVie Announce Partnership to Develop a Novel Trispecific Antibody Candidate in Multiple Myeloma
Low
Report
Simcere Zaiming and AbbVie Announce Partnership to Develop a Novel Trispecific Antibody Candidate in Multiple Myeloma
1/13
09:00 am
abbv
AbbVie and Simcere Zaiming Announce Partnership to Develop a Novel Trispecific Antibody Candidate in Multiple Myeloma
Low
Report
AbbVie and Simcere Zaiming Announce Partnership to Develop a Novel Trispecific Antibody Candidate in Multiple Myeloma
1/13
08:31 am
abbv
AbbVie and REGENXBIO Announce Updates on the ABBV-RGX-314 Clinical Program
Low
Report
AbbVie and REGENXBIO Announce Updates on the ABBV-RGX-314 Clinical Program
1/9
08:00 am
abbv
AbbVie to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Low
Report
AbbVie to Present at the 43rd Annual J.P. Morgan Healthcare Conference
1/8
08:00 am
abbv
AbbVie Inc. (NYSE: ABBV) had its price target lowered by analysts at Truist Financial Co. from $215.00 to $211.00. They now have a "buy" rating on the stock.
Low
Report
AbbVie Inc. (NYSE: ABBV) had its price target lowered by analysts at Truist Financial Co. from $215.00 to $211.00. They now have a "buy" rating on the stock.